483
Charu Aggarwal, MD, MPH, Hematology-Oncology DivisionCharu Aggarwal, MD, MPH, Hematology-Oncology Division – FDA 483, Mar 28, 2017
Record Details
An FDA inspection of Charu Aggarwal, MD, MPH, Hematology-Oncology Division in Philadelphia, PA, revealed significant deficiencies in the conduct of a clinical investigation. The principal investigator and staff failed to adhere to the study protocol, lacked adequate oversight, and maintained inadequate and inaccurate case histories. These issues indicate serious non-compliance with clinical trial regulations.
- Inspection date
- March 28, 2017
- Product type
- drugs
View Company Profile
ID · d67ab368-a7a4-4177-b7bf-d00b89e6180f
Other documents for Charu Aggarwal, MD, MPH, Hematology-Oncology Division
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.